Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Delivery Improvements of the AMD-drug Lucentis on the Way
The anti-VEGF Fab Lucentis is the new standard of care to treat AMD because it can improve visual acuity. Competitor drugs directed against the same and innovative targets are applied with non-intravitreal forms of administration to avoid the unease of intra-vitreal injection. - September 20, 2006 - La Merie Business Intelligence
Gentris Promotes Karen Nield to VP, Finance and Human Resources
Gentris Corporation (Gentris), a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions, today announced the promotion of Karen Nield to VP, Finance and Human Resources. Prior to this promotion Nield held the position of Executive Director, Finance. - September 15, 2006 - Gentris Corporation
Kerr Drug Introduces Free Translation Service in 11 Charleston
Local pharmacy chain provides safe, convenient healthcare services to Spanish speaking patients. - September 11, 2006 - Kerr Drug
Biologics Define New Standard of Therapy in Psoriasis
Anti-TNF agents set the new gold standard of psoriasis treatment which could be outperformed by smarter next generation biologics and small molecules in safety and convenience. - September 08, 2006 - La Merie Business Intelligence
Menscience Androceuticals to use Liferro
Menscience Androceuticals, the leader in cosmeceutical-grade skin care to use Liferro to manage business. - September 01, 2006 - Liferro
Business Trends Quarterly and a Leading Independent Research Firm Announce Official Media Partnership on Key Upcoming Events
Gartner, Inc. and Business Trends Quarterly (BTQ) announce a joint Media Partnership on the following upcoming events in 2006: Financial Services Technology Summit (Aug. 28-30, Boston, MA) IT and Software Asset Management Summit (Sept. 18-20, Orlando, FL) Application Development Summit &... - August 24, 2006 - Analysts In Media
Analysts in Media Announces Release of Q3 Edition of Future Pharmaceuticals
Today, Analysts In Media, Inc. (AIM) released the Q3 August 2006 edition of Future Pharmaceuticals (FP) a high-level publication both online and in print, designed to provide senior-level business and technology executives with an in-depth analysis of, and key insight into market trends and... - August 24, 2006 - Analysts In Media
Baxa Opens Skills Training, Academics and Resources (STAR) Center for Pharmacy and Cleanroom Skills Training
Baxa Corporation is holding a ribbon-cutting ceremony today for a new, first-in-the-industry, strategic training center. The STAR Center offers pharmacy training for peak performance. First classes begin September 20th at the Englewood, Colo., location.. The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn. - August 23, 2006 - Baxa Corporation
Gentris Partners with FALCO Biosystems
Companies establish Japan’s first GLP-compliant pharmacogenomics laboratory. - August 22, 2006 - Gentris Corporation
New Report Addresses Major Problem with Opioid Pain Relievers
Constipation, a troublesome side effect of opioid analgesics, can be prevented and should be considered whenever these agents are prescribed. - August 21, 2006 - Pain Treatment Topics
Free Webcast - Eight Ways to Pay Less for Your Medications
Free Webcast to Discuss Tips to Paying Less for Medications. - August 21, 2006 - StaceyLloyd.com
PharmiWeb.com Applies Google Appliance
Online publisher and e-Business specialists PharmiWeb Solutions today announces that it will be empowering users of its pharmaceutical industry portal PharmiWeb.com with new Google-powered search facility. An online publication in the PharmiWeb Solutions stable, PharmiWeb.com is the de facto... - August 19, 2006 - Pharmiweb Solutions
King Bio Creates New Grant to Provide Natural Medicines for those in Need
King Bio, manufacturer of homeopathic remedies, seeks qualified service providers interested in receiving homeopathic medicines and training in order to more effectively meet the health care needs of their clients. The Community Outreach Program Grant provides totally free of charge a set of homeopathic remedies tailored to each group’s needs, education on homeopathy, and supporting resources. King Bio hopes that our communities will experience greater health and well-being with this grant. - August 18, 2006 - King Bio
The Crowded Field of VEGF and VEGF-R Targeting Drugs
The versatility of the vascular endothelial growth factor (VEGF) signalling pathway as a validated target and its excellent tractability explain a crowded field of drugs of all classes. - August 17, 2006 - La Merie Business Intelligence
Keynote Speakers Announced for Modern Drug Summit
Mahdi Fawzi of Wyeth Research, Allen D. Roses of GlaxoSmithKline, James Summers of Abbott Laboratories, Keith James of Pfizer and Lester Crawford, Former FDA Commissioner and Senior Counsel of Policy Directions, Inc are announced as Keynote Speakers for the 2nd Modern Drug Discovery & Development Summit (M3D). - August 04, 2006 - GTCbio
A Full Pipeline of Follow-on TNF-Antagonists
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence
Kerr Drug Recognized by American Pharmacists Association Foundation for Contributions to Health Care Quality
North Carolina-based Community Pharmacy Receives 2006 Pinnacle Award. - July 25, 2006 - Kerr Drug
Analysts in Media Announces Release of Q3 Edition of Business Trends Quarterly
Today, Analysts In Media, Inc. (AIM) released the Q3 July 2006 edition of Business Trends Quarterly (BTQ), a high-level publication designed to provide senior-level business and technology executives with an in-depth analysis of, and key insight into market trends and innovative technologies on a quarterly-basis. - July 22, 2006 - Analysts In Media
Introducing KnowPharma.com, New Technology and Product Resource for Pharmaceutical and Biopharmaceutical Professionals
KnowPharma.com allows pharmaceutical and biopharmaceutical industry professionals to source new technologies, services and products at any stage of the value chain, from discovery and R&D through manufacturing, packaging and distribution. The site cuts through the search engine clutter and offers specific and effective results on technology, products or services. - July 13, 2006 - KnowPharma.com
Seven Finalists Selected for The BioWest 2006 Venture Showcase Competition, Presenting World-Changing Technologies
Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association
Canada's ADHD Drug Warning Lifts Lid on Questionable Diagnosis
Last month, Canada's health ministry issued a new warning concerning the controversial drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) fuelling further calls for an outright ban. - July 04, 2006 - Psychbusters
Baxa to Launch STAR Center for Professional Pharmacy and Cleanroom Training at ASHP Annual Meeting
Baxa Corporation will announce the development of a professional Skills Training, Academics and Resources (STAR) Center for pharmacy and cleanroom skills training at the Annual Meeting of the American Society of Health-System Pharmacists in Orlando, Florida. The STAR Center, a state-of-the-art facility designed for cleanroom and pharmacy practice demonstration, is located at the company’s world headquarters south of Denver, Colorado. - June 23, 2006 - Baxa Corporation
Transforming the Face of Pharmaceutical Industry Reporting
Online publisher and e-Business specialists PharmiWeb Solutions today announces a new initiative that it believes will transform the face of publishing in the pharmaceutical industry, via its industry-sponsored portal, www.pharmiweb.com. PharmiWeb.com is widely regarded as the leading online... - June 22, 2006 - Pharmiweb Solutions
Biogenerics and New Technologies Compete with 1st Generation Major Products
The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence
WellTouch Goes International
Marketing and services firm signs licensing deal with Mexico City-based Signufarma. - June 20, 2006 - PharmaCentra
MenScience Finds Sweet Smell of Success in Sweaty Underarms
Along with all the perks of summer (beaches, barbecues and bikinis), comes the bad—sunburn, vacation traffic and, of course, a massive increase in body odor. Fortunately, MenScience, the leader in cosmeceutical-grade skin care, has unveiled its new Advanced Deodorant just in time for the... - June 09, 2006 - MenScience Androceuticals
LGC and Gentris Corporation Announce Licensing Agreement
Gentris obtains rights from LGC to make, use and sell diagnostic products and services which include testing for the CYP2D6*4 polymorphism. - June 08, 2006 - Gentris Corporation
Cornerstone BioPharma, Inc. and Athlon Pharmaceuticals Sign Co-Promotion Agreement
Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced the company has signed a co-promotion agreement with Athlon Pharmaceuticals... - June 06, 2006 - Cornerstone BioPharma
Imminent Launches of New EPO Products and Consolidation of the Biogenerics Field
The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by... - June 03, 2006 - La Merie Business Intelligence
Localized Delivery of PDE-4 Inhibitors to Open the Therapeutic Window
The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence
Resveracine Ultimate Antioxidant Powerhouse, Now Offered by Advanced Nutriceuticals
Advanced Nutriceuticals now offers Resveracine, heralded as "The Ultimate Antioxidant Powerhouse." Resveracine is formulated by Dr James Chappell to provide the highest level of free radical scavenging antioxidants known in the world today. - May 23, 2006 - Health and Beauty Net
The Next Generation of Interferons Needs Improvement in Efficacy and Safety
The interferon alpha market is smaller than the interferon beta market, but is characterized by far more products and R&D projects. Conversion of the interferon alpha market to pegylated products explains why new R&D is focused on interferon alpha variants or other subtypes with improved pharmacodynamic and safety properties. - May 19, 2006 - La Merie Business Intelligence
Now available on CD: Baxa Corporation Exhibitor’s Theatre Offering, 'What’s Next with USP 797?' from ASHP Midyear Clinical Meeting
Colorado-based pharmacy products manufacturer, Baxa Corporation now has a CD available of the presentation, 'What’s Next with USP 797?' from the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. Eric Kastango, MBA, RPh, discussed the proposed changes to the USP 797 guidelines for sterile compounding and the impact on the hospital pharmacy practice. - May 10, 2006 - Baxa Corporation
RNA Interference (RNAi) is Coming of Age as a Therapeutic Modality
The Business Intelligence firm La Merie S.L. reported today that the RNAi therapeutic pipeline is rapidly filling and advancing towards clinical development. Four RNAi therapeutic projects are in early clinical development. At least 32 RNAi projects are in preclinical development in a variety of... - May 10, 2006 - La Merie Business Intelligence
JKZ Ventures Launches New How To Guide to Reduce Pharmacist's Dispensing Errors
Ten years of proven technique reduce or eliminate your dispensing errors. - May 04, 2006 - JKZ Ventures, Inc
Pharmaceutical Resources Group Welcomes Mary Lou Freathy, JD, as its Newest Member
Freathy Brings Experience in Pharmaceutical Compliance and Quality Assurance to the Network. - May 04, 2006 - Pharmaceutical Resources Group
Gentris Announces UGT1A1 Sub-Licensing Agreement
Gentris obtains rights from Mayo Foundation for Medical Education and Research to provide genetic testing services for mutations associated with adverse reactions to irinotecan. - April 26, 2006 - Gentris Corporation
Gentris Corporation Introduces Human Genomic DNA Reference Controls for CYP2D6 Gene
Gentris Corporation, a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions, today announced the availability of Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6). - April 13, 2006 - Gentris Corporation
Pharmaceutical Resources Group is Accepting New Members for its Free Online Network
PRG is Currently Accepting Pharmaceutical, Biotechnology, and Medical Device Professionals. - April 07, 2006 - Pharmaceutical Resources Group
Dawn has Broken for Obesity Treatment with Cannabinoid Receptor (CB1) Antagonists
Tremendous impetus to discovery of novel CB1 antagonists by first-in-class CB1 receptor antagonist rimonabant under review by FDA and EMEA - February 22, 2006 - La Merie Business Intelligence
Top 20 Biologics Now with Sales of US$ 37.7 Bln in 2005
The Top 20 blockbuster recombinant proteins and antibodies achieved record sales of US$ 37.7 bln in the year 2005 while combined sales of the 12 Top selling classes of recombinant proteins and antibodies reached the US$ 50 bln threshold. - February 15, 2006 - La Merie Business Intelligence
Emerging Diabetes Drugs in Early Development
The complexity of glucose metabolism and the number of cellular processes affected by diabetes provides ample space for new drug targets and for first-in-class molecules. Some of them have reached or are close to early clinical development in type 2 diabetes. - January 31, 2006 - La Merie Business Intelligence
Emerging Pharmaceutical Sales & Marketing Company CaraMedica Closes Series A Funding Round
Company poised for national rollout of products focused on the rapidly growing cosmetic/aesthetic surgery market. - December 21, 2005 - CaraMedica Pharmaceuticals
Gentris Announces Promotion and Strategic New Hire
Scott Clark promoted to Vice President of Research and Development; Heath Knight joins as Vice President of Business Development - December 15, 2005 - Gentris Corporation
New Life Scientific, Inc. and Telomolecular Corp Announce Strategic Alliance Agreement
New Life Scientific, Inc. (OTCBB:NWLF - News) and Telomolecular Corp, have announced a strategic alliance to develop products that treat aging and age-related disease. New Life Scientific, Inc a company engaged in developing pharmaceutical products as well as managing PharmaTrials International... - December 05, 2005 - New Life Scientific, Inc.
Gentris Joins Personalized Medicine Coalition
Educational and advocacy group to promote the advancement and understanding of personalized medicine. - December 05, 2005 - Gentris Corporation
Baxa to Sponsor Exhibitor’s Theatre: “What’s Next with USP 797?” at ASHP Midyear Clinical Meeting
Colorado-based pharmacy products manufacturer, Baxa Corporation is sponsoring a program at the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. The speaker will discuss the proposed changes to the USP 797 guidelines for sterile compounding and their impact on pharmacy practice. - December 02, 2005 - Baxa Corporation
Baxa to Launch ValiMed™ Medication Validation System at ASHP Midyear Meeting
Baxa Corporation announces its launch of the ValiMed System for medication safety at booth no. 2221 at the American Society of Health-System Pharmacists Midyear Meeting to be held December 4 – 8, 2005 in Las Vegas, Nev. The innovative ValiMed Technology offers validation of medication to ensure the type and strength of high-risk medications. The technology also validates narcotic returns and identifies counterfeit medications. - November 29, 2005 - Baxa Corporation
Cardiovascular safety determines the direction of PPAR agonist R&D
The two peroxisome proliferator-activated receptor (PPAR) gamma agonists pioglitazone and rosiglitazone approved for treatment of type 2 diabetes achieved combined 2004 global sales of US$ 3.96 bln shared between Takeda & Eli Lilly (52 %) and GlaxoSmithKline (48 %). - November 28, 2005 - La Merie Business Intelligence
Baxa Corporation and Carmel Pharma ab End Exclusive Distribution Agreement for PhaSeal®
Carmel Pharma elects to end Baxa distribution and establishes a US headquarters: Baxa Corporation announced today that its exclusive US distribution rights for the PhaSeal Products will end on December 31, 2005. The products’ Swedish manufacturer, Carmel Pharma ab, has elected not to continue the agreement. Over the course of the agreement, Baxa more than tripled annual PhaSeal product sales. Today, PhaSeal is used in more than 300 leading cancer treatment facilities nationwide. - November 14, 2005 - Baxa Corporation